Abstract
Colorectal cancer (CRC) is the third most prevalent cancer in the world. Globally, it has been estimated that about 1.4 million new cases of colorectal cancer are diagnosed every year. CRC is a multifactorial disease that arises due to genetics as well as epigenetic alterations in a number of oncogenes, tumor suppressor genes, mismatch repair genes, as well as cell cycle regulating genes in colon mucosal cells. These molecular alterations have been considered as potential CRC biomarkers because they can provide the physicians with diagnostic, prognostic and treatment response information. The goal is to identify relevant, cheap and applicable biomarkers that contribute to patient management decisions, resulting in direct benefits to patients. In this review, we will outline the most currently available and developing tumor tools, and blood molecular biomarkers. Also, we will illustrate their diagnostic, therapeutic and prognostic applications.
References
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 23, 2011·Current Colorectal Cancer Reports·Graeme P Young, Linda J W Bosch
Aug 13, 2013·Virchows Archiv : an International Journal of Pathology·Jens NeumannAndreas Jung
Apr 30, 2017·World Journal of Gastrointestinal Oncology·Michail GalanopoulosGerassimos J Mantzaris
Citations
Aug 23, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Yang WangWei Li
May 3, 2019·Clinical and Experimental Medicine·Zora LasabováLukáš Plank
Oct 20, 2018·Oncology Letters·Zijian LiuQuanxiang Luo
Sep 1, 2019·BMC Cancer·Muneer J Al-HusseiniOmar Abdel-Rahman
Jun 22, 2018·Oncology Letters·Luis UbillosNora Berois
Apr 6, 2019·BMC Cancer·Yang-Yang WuFa-Quan Lin
Sep 25, 2019·International Journal of Molecular Sciences·Hsin-Hua ChungYu-Lueng Shih
Oct 24, 2018·Surgical Endoscopy·Jin-Sung JungYoung-Eun Joo
Sep 25, 2018·Journal of Cellular Biochemistry·Hamid Cheshomi, Maryam M Matin
Dec 19, 2019·Biological Research·Guangchuan WangLipan Peng
Aug 12, 2020·Journal of Cancer Research and Clinical Oncology·Yu LiZhuoli Zhang
Oct 5, 2017·PloS One·Dae-Seong MyungYoung-Eun Joo
Nov 22, 2018·Lipids in Health and Disease·Tong LiJiusheng Deng
Jan 10, 2019·Molecular Cancer·Paul Laissue
Jul 2, 2019·Future Oncology·Xin ZhouXian-Ming Mo
Dec 8, 2017·BioMed Research International·Gaia PelusoNicola Carlomagno
Sep 12, 2019·Genetic Testing and Molecular Biomarkers·Lei Zhang, Jiehong Mao
Jun 26, 2020·Cancer Cell International·Qiliang PengYaqun Zhu
Oct 9, 2020·International Journal of Colorectal Disease·Eivor Alette LaugsandFrank Skorpen
Jan 27, 2021·Medicina·Ayushi RaiGulam Mustafa Hasan
Feb 9, 2021·Human Antibodies·Abdullah O Alamoudi
Mar 6, 2021·Analytical and Bioanalytical Chemistry·Wenxian ZhangChonghai Xu
Nov 14, 2020·Lab on a Chip·Bo DaiSonglin Zhuang
Jul 1, 2021·Journal of Healthcare Engineering·Haoran ZhaoZengfu Song
Aug 29, 2021·Pharmaceutics·Ana Luiza C de S L OliveiraRaimundo Fernandes de Araújo Junior
Sep 22, 2021·Biomarkers in Medicine·Siyu HeMei Lin
Sep 5, 2021·Chemical Biology & Drug Design·Masomeh MalekiMaryam Majidinia
Apr 11, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chun FengYanjie Zhang
Nov 14, 2019·Oncology·Yong TianLati Mu
Nov 10, 2021·Journal of Cellular and Molecular Medicine·Chinasa Valerie OlovoMin Xu
Dec 8, 2021·Scientific Reports·Zhi Yao MaWai K Leung